Audrey’s Life Science Meeting Picks for Oct. - Nov., 2009 (Oct. 18th Edition)

*************************************************************************************

Palo Alto AWIS, Monday Evening, October 19, 2009

Topic: “Stories of AWIS”Speaker: Jaleh Daie, Ph.D Managing partner at Aurora Equity And Past President of National AWIS ScheduleDate and Time: Wednesday, Oct. 19, 2009, 7:00 pm - 9:00 pm 7:00-7:30 pm Networking and light supper7:30-7:45 pm Announcements7:45-8:45 pm Program8:45-9:00 pm DiscussionLocation: Palo Alto Research Center (PARC), 3333 Coyote Hill Road, Palo Alto Directions to PARC. For details and to register, http://www.acteva.com/go/pa-awis

Welcome!! You don’t need to be a member to attend.All scientists, students, and their friends are welcome. Men too!Members pay $4 and non-members pay $7 to offset the cost of food.

Topic DescriptionDr. Daie will share stories about AWIS history, its impact and her years as its president. With a versatile background in academia, philanthropy, science policy, education, non-profit, public service, and finance, Jaleh has a unique perspective on present and future challenges that face the scientific community and our society in general

Speaker Bio

Dr. Daie is currently managing partner at Aurora Equity, a Palo Alto-based company investing in technology start-ups. Her career includes serving as head of science and senior advisor at the Packard Foundation, over 20 years as professor and administrator at Rutgers Univ. and UW-Madison, Chair of the Council of Scientific Society Presidents, and science liaison to the President's National Sci &Tech Council while on assignment in Washington DC. She was inducted into the Women in Technology International Hall of Fame in 1996.

She was named one of Silicon Valley/San Jose Business Journal's 40 people to watch under the age of 40 in 2006, and one of Silicon Valley's Women of Influence in 2008..

     A donation of $5 for members or $10 for non-members is requested at the door to help cover the cost of refreshments. For more information about AWIS Palo Alto, visit our website at www.pa-awis.org.

*******************************************************************************FountainBlue's Life Science Entrepreneurs' Forum, Monday Evening, Oct. 19, 2009

Topic:” Software Meets Healthcare Services: Health IT Platforms, Pharmaceutical Tracking, Remote Monitoring and Beyond”

*       Facilitator Russell Singleton, President and CEO, Molecular Image*       Panelist Shannon Kelley, Director of Marketing, Intuitive Surgical*       Panelist John Steuart, Claremont Ventures

1 5/6/2023

*       Panelist Evgeny Zaytsev, Helix Ventures*       Panelist Steve Douglas, CEO, Data Physics Research*       Panelist from Kaiser TBD*       Presenting Entrepreneur Arthur W Douville, MD, CEO, Clinsensus*       Presenting Entrepreneur TBD*       Presenting Entrepreneur TBDDate & Time:    Monday, October 19 from 5:30 - 7:30 p.m.Location: Intuitive Surgical, 1266 Kifer Road, Building 101, SunnyvaleCost:  $20 members, $25 partners, $30 general, plus a $1 fee.$100 plus fee for FountainBlue Ongoing membership, admission, and free giftRegistration:   We will plant a tree for everyone who pre-registers by noonon 10/16 using the PayPal link at http://www.svlifescience.com . Late and on-site registration is $40 ife-mail is time stamped after that, regardless of membership status.Audience: Entrepreneurs, intrapreneurs and investors, no serviceproviders please

Topic DescriptionThis month we examine the convergence of technology and health care, andprofile software solutions which benefit health service professionals, fromhealth IT platforms to pharmaceutical tracking, health monitoring and more.

Information and Registration: NO SERVICE PROVIDERS PLEASE.

******************************************************************************Bio2Device Group, Tuesday Morning, Oct. 20, 2009

Topic: “Deciding Who Decides, Deciding, and Doing: A BioPharma Primer”Speaker: Joseph A. Carlino, Ph.D., Principal, Carlino Consulting; Project Management and Drug Development Consulting.Date and Time: Tuesday, October 20, 2009, 8:30 – 10:30 amLocation: Sunnyvale City Council Chambers, 456 W. Olive, Sunnyvale, CA (across the street from Sunnyvale Public Library)Cost: FreeParking: On street and in NOVA and library parking lots across the street.

Topic DescriptionWitnessing or participating in slow, inefficient, and obtuse decision-making can be one of the most professionally painful and de-motivating processes in the BioPharma industry. It is also something over which project teams and even those on oversight/management committees often feel they have little control. However, understanding the roles and responsibilities of those involved in decision-making, knowing what makes a good decision, and leveraging that information in an objective and project-centric fashion, can help cut through inefficiencies and self-interests and achieve a clear, actionable decision.

Joe will use biopharma industry examples to illustrate some of these challenges, and will highlight how individuals at all levels can understand, manage, influence, and execute upon decisions to enable greater accountability, ownership, and progress. Participants are also encouraged to bring their own (blinded) decision challenges for evaluation and discussion.

Speaker BioJoseph A. Carlino, Ph.D. is an independent Biopharmaceutical Project Management (PM) and Drug Development consultant with over 30 years of experience in biomedical and pharmaceutical R&D, including more than 20 years in BioPharma PM. He received his Ph.D. in Pathobiology/ Immunology from Columbia University, and worked at institutions including Memorial Sloan-Kettering Cancer Center, Cetus, Celtrix, and Chiron. His clients have included a spectrum of small-to-medium sized biotech companies where he leads project teams, manages corporate partners, drives project decisions, defines and implements team and

2 5/6/2023

committee structures, and writes development plans. Joe is an active speaker on drug development and PM, and contributes to the management of professional association in Northern California such as Project Managers in Pharmaceuticals (PMPharma, www.projmgr.org) and BioScience Forum (BioSF, www.biosf.org). **************************************************************************BioScience Forum, Wednesday Evening, Oct. 21, 2009

Topic: "Precision Measurements in Biology"Speaker: Stephen Quake, D. Phil., Lee Otterson Professor of Bioengineering and Applied Physics, Stanford University and Howard Hughes Medical Institute

Date and Time: Wednesday, Oct. 21, 2009 6:00 PM – Networking7:00 PM – Dinner8:00 PM - Presentation

Location: The Clarion Hotel, 401 East Millbrae Avenue, Millbrae, CA650-692-6363 | Map Price: $50 before 11PM, Monday, Oct. 19$60 on-site$30 full-time students pre-registration$35 full-time students on-site Acteva fees are added to the above prices

Topic Description Is biology a quantitative science like physics? Stephen will discuss the role of precision measurements in both physics and biology, and argue that in fact both fields can be tied together by the use and consequences of precision measurement. The elementary quanta of biology are twofold: the macromolecule and the cell. Cells are the fundamental unit of life, and macromolecules are the fundamental elements of the cell. Stephen will describe how precision measurements have been used to explore the basic properties of these quanta, and more generally how the quest for higher precision almost inevitably leads to the development of new technologies, which in turn catalyze further scientific discovery. In the 21st century, there are no remaining experimental barriers to biology becoming a truly quantitative and mathematical science.

Speaker Biography           Stephen Quake is a founder of Fluidigm and Helicos BioSciences Corporation. He studied physics (BS 1991) and mathematics (MS 1991) at Stanford University, where he was elected to Phi Beta Kappa and won the Firestone Prize for Undergraduate Research. His senior thesis research on the manipulation of single DNA molecules with optical tweezers won the Apker Award (1991) from the American Physical Society, an honor given to the best undergraduate physics research nationwide. Quake also won a Marshall scholarship and a National Science Foundation graduate fellowship, which he used to earn a doctorate in physics from Oxford University (1994). His thesis research was in statistical mechanics and the effects of knots on polymers. He then spent two years as a post-doc in Nobel Laureate Steven Chu's group at Stanford University continuing his research in single molecule biophysics. Quake joined the faculty of the California Institute of Technology in 1996, where he rose through the ranks and was ultimately appointed the Thomas and Doris Everhart Professor of Applied Physics and Physics (2004). At Caltech, Quake received “Career” and “First” awards from the National Science Foundation and National Institutes of Health (1997), and was named a Packard Fellow (1999). These awards supported a research program that began with single molecule biophysics and soon expanded to include the invention of microfluidic large scale integration, and its application to biological automation. He moved back to Stanford University in 2005 to help launch a new department in Bioengineering, where he is now the Lee Otterson Professor and co-Chair.

3 5/6/2023

 Quake’s contributions to the development of new biotechnology at the interface between physics and biology have been recognized by awards from the MIT Technology Review Magazine, Nature Biotechnology, Forbes, and Popular Science. He won one of the inaugural NIH Director’s Pioneer Awards (2004) and became an investigator of the Howard Hughes Medical Institute (2006).   Quake has published more than 100 research papers in numerous leading scientific journals, including Science, Nature, and P.N.A.S. His paper describing the invention of the micromechanical valve that forms the basis of microfluidic large scale integration has been cited more than 500 times, and his top ten most cited papers all have more than 100 citations each. The practical applications of his research have led to more than 60 issued U.S. patents, as well as numerous international patents

**************************************************************************

 Engineering in Medicine and Biology Society (EMBS), Wednesday Evening, Oct. 21, 2009

Topic: “ The Application of Photocoagulation Technology to the Treatment of Ocular Disease”Speaker: Steve Hanlon, VP for Research and Development, OptiMedica Corp.Date and Time: Wednesday,  October  21, 2009,  7:30 pmNew location:  Room M-114, Stanford University Medical School Optional dinner, new location: Nexus Cafeteria in the Clark Center, 6:15 pm (no host, no reservations)

Topic DescriptionOptiMedica Corporation was founded in January 2004 to develop a radically new technology for the treatment of ocular disease. Initially developed at Stanford University, and exclusively licensed to the OptiMedica Corporation, the PASCAL® Method of Photocoagulation is used to treat a variety of retinal conditions including diabetic retinopathy, age-related macular degeneration, and retinal vascular occlusive disease. The PASCAL Photocoagulator provides significantly improved performance for the physician and an enhanced therapeutic experience for the patient.  The company received FDA clearance for its PASCAL Photocoagulator device in 2005 and secured funding from Kleiner, Perkins, Caufield & Byers and Alloy Venture Partners in the same year.

The talk will include a discussion of the technology behind the PASCAL Photocoagulator and the application of the technology to retinal eye diseases.  In addition, the growth of OptiMedica and the challenges of product development in an early stage company will be discussed. 

Speaker Biography Stephen P. Hanlon has more than twenty-five years of leadership experience in medical technology research and development, with areas of focus including stereotactic radiosurgery, image-guided surgery, implantable devices, electrosurgery and dialysis products.   He is currently Vice President, Research & Development for OptiMedica Corporation in Santa Clara, California. Prior to joining OptiMedica, Mr. Hanlon was vice president of research and development for Boston Scientific's Neurovascular Division, where he oversaw a 100-person multi-disciplinary department and numerous successful product launches.  He also previously served as vice president of operations for Photoelectron Corp. as well as vice president and general manager of the Radionics division of Tyco Healthcare .

Mr. Hanlon received a B.S. in electrical engineering from the University of Wyoming, an M.S. in electrical engineering from Arizona State University and an M.B.A. from the University of Colorado.

********************************************************************************NCC East Bay Sub-Chapter, ACRP, Wednesday Evening, Oct. 21, 2009

4 5/6/2023

Event: 2nd Annual Networking EventDate and Time: October 21, 2009, 5:00 – 7:00 PM Location: Claremont Resort and Spa , Paragon Private Dining Room , 41 Tunnel Road , Berkeley, CA 94075

Appetizers provided/Cash bar www.claremontresort.com

******************************************************************************************Bay Bio Therapeutic Breakfast, Thursday Morning, Oct. 22, 2009

Topic: “Funding for Stem-Cell Research: a Changing Landscape”Moderator: Stacy Taylor, Partner, DLA Piper LLP (US)Panel Speakers:Elona Baum, Esq., General Counsel, CIRMGregory A. Bonfiglio, Managing Partner, Proteus Venture PartnersA. Franklin Rice, MBA, Chief Financial Officer and Director, VistaGen Therapeutics, Inc.Rodney Young, Chief Financial Officer, StemCells Inc.Date and Time: Oct. 22, 2009, 8:00 – 10:00 amLocation: Elan Pharmaceuticals, Inc., 180 Oyster Point Blvd., South San Francisco, CA, 94080DirectionsRegister at http://www.baybio.org/wt/home/Funding_StemCellsCost: Early Bird Registration through Oct. 20:$10.00 - BayBio Members$20.00 - Non-Members

On-Site Registration, Oct. 22:$20.00 - BayBio Members$40.00 - Non-Members

Topic DescriptionEmbryonic stem cells have come to represent potential salvation for many people suffering from incurable diseases. State governments, most notably California with the passage of Prop 71, have taken the unusual step of funding biomedical research – usually done with federal grants – because of federal decisions to restrict funding. Recently President Obama signed an executive order ending an 8½-year ban on federal funding for the creation of new embryonic stem cell lines, paving the way for a significant amount of federal funds for the new research and development possibilities. With the climate for stem-cell research funding changing rapidly, a panel of industry executives will discuss funding opportunities – in the state of California, nationally and internationally, how companies can directly benefit and what pitfalls to avoid.******************************************************************************************San Jose Biocenter, Thursday, Oct. 22, 2009

Topic: “Meet With... Genentech.” Date and Time: Thursday., Oct., 22 2009 | 9:00am-4:00pm Location: The San Jose BioCenter, 5941 Optical Court, San Jose, CA 95138Click here for Venue Directions» Topic DescriptionEmerging companies find it increasingly difficult to reach the right person when seeking funding and/or partners. Through the “Meet with...” Series, we provide emerging companies with greater access to partnering and/or financing opportunities.

In this session, Genentech Partnering’s Business Development organization will talk to potential licensees to

5 5/6/2023

first explain what they are looking for in a company.

After the presentation, each attendee will be granted a private meeting with Anna Williamson - Senior Manager of Business Development at Genentech, Inc. - Peter Condon - Associate Director of Business Development at Genentech, Inc.

ApplicationAttendees must apply and be approved to attend. To apply, please send your Executive Summary to Aurélie at aurelie@sjbiocenter.com by October 2nd . The Review Board, composed of the BioCenter management team, sponsors, partners and mentors, will meet in early September to consider your application. You will then be notified if your application is accepted or rejected. Registration must be completed upon approval to secure your meeting slot.

• Application fee: FREE• Registration for one: $100• Registration for two: $175• Registration for three: $225• BioCenter Members: Free*All registrations include lunch*

Speaker BiosAnna Williamson, Senior Manager, Business Development, Genentech Inc. Anna Williamson is a Senior Manager in the Business Development Department at Genentech. Anna's responsibilities include sourcing, evaluating, and in-licensing research technologies and therapeutic products. While at Genentech, Anna has developed strategic collaborations with academic institutions and with companies such as Curis, Sangamo, Abbott and Symphogen. Prior to joining Genentech in 2004, Anna worked at the University of California Office of Technology Transfer where she was responsible for managing and out-licensing a portfolio of life sciences inventions from multiple UC campuses. Anna holds a BA in Natural Sciences and a Ph.D. in Neuroscience from the University of Cambridge, UK, and carried out post-doctoral research at the University of Colorado and the University of California, San Francisco.

Peter Condon, Associate Director, Business Development, Genentech Inc. Peter Condon has worked at Genentech since 2000. Peter holds an MBA from the Wharton Business School, and has an undergraduate degree in economics from Harvard University. At Genentech, Peter began his career in the Market Development group where he conducted the launch planning efforts for Xolair and led the market research and forecasting activities for Genentech's specialty therapeutics group. In 2003, Peter joined Business Development in the Oncology licensing group and has successfully completed a number of research and product licensing transactions. Prior to Genentech, Peter worked as a consultant to health care companies in the Health Care Group at Booz Allen & Hamilton.

**********************************************************************

BACRR, Monday Bag Lunch, Oct. 26, 2009

Topic: “Global Regulatory Strategy Regulatory’s Piece of the Puzzle”Speaker: Meredith Brown-TuttleDate and Time: OCTOBER 26, 2009, 12:00 to 2:00 pmLocation: Jazz Pharmaceuticals, 3180 Porter Drive, Palo Alto, CA 94304, USAPhone:(650) 496-3777Food for lunch:” Bring your own bag lunch event”

Please share the event below to your colleagues and send your RSVP to MariaShabe at mlshabe@yahoo.com ON OR BEFORE OCTOBER 21, 2009. Jazz Pharmaceuticals

6 5/6/2023

will prepare name badges prior to the meeting.

Topic Description

As drug companies seek to expand into global markets and get new drugs tomarkets quicker, these companies are increasingly conducting drug and biologicclinical studies outside the United States. The regulatory affairsprofessional must keep abreast of the ever changing regulatory climate and beable to complete IND like submissions in a variety of formats and country/regulatory agency specific requirements. This presentation will provide anoverview of the global regulatory requirements, factors, considerations andtimelines for submission and approval of clinical trial dossiers for Canada,EU, South Africa, Australia, Asia and South America.

Speaker Bio

Meredith Brown-Tuttle’s seventeen years experience in biotech incorporates allaspects of drug, device and biologics development including clinical research,data management, medical writing, and regulatory affairs. She has held seniorregulatory positions at several Bay Area biotech companies and a full-serviceCRO. She has written and managed numerous drug and biologic submissions to U.S. and international regulatory agencies, developed regulatory strategy for bothdevice and drug companies, and conducted worldwide regulatory intelligence.She is also the author of the book, “IND Submissions: A Primer,” published byBarnett. Ms. Brown-Tuttle graduated with a bachelor’s degree in biologicalpsychology from San Jose State University.

BACRR would like to thank Theresa Haedrich for hosting this event on behalf ofJazz Pharmaceuticals.**************************************************************Windhover’s PharmAsia Conference, Oct. 26, 1:00 pm – Oct. 28, 2:00 pm, 2009

Event: PharmAsia ConferenceMeet the Most Senior Level Speakers in the Business, including:

Frank JiangVP Global R&D Head, China R&D HeadSanofi-Aventis

Tony ZhangManaging Director and Site HeadEli Lilly Global R&D, China

Samantha DuCEOHutchison Pharma

Ge LiCEOWuXi Apptec

Ding DingSenior Equity AnalystChina Health Care, Susquehanna

Andrew von EschenbachFormer FDA Commissioner

Alex WuCEOCrown Bio

G.V. PrasadVice Chairman and CEODr. Reddy’s Laboratories

Kiran MarthakCEOVeeda

Robert ArmstrongVP, Global External Research and DevelopmentEli Lilly and Company

7 5/6/2023

Jonathon WangSenior Managing Director, AsiaOrbiMed Advisors

Zhu ShenCEOBioForesight

Yael Weiss, MD, PhDDirector, Licensing And External Research Merck Research Laboratories

Li ChenChief Scientific OfficerRoche R&D Center (China) Ltd.

Song RuilinExecutive Director-General Research Center for Medicinal PolicyChinese Pharmaceutical Association

Dates: Oct. 26-28, 2009Location: Intercontinental Mark Hopkins • San FranciscoCost: $1,795 , including two nights at the Intercontinental Mark HopkinsSee detailed agenda at http://www.windhover.com/windhover/content/conferences/passchedule09.asp

Topic Description PharmAsia Summit is THE most strategic level meeting where senior level biotech and pharma executives share real-life case studies on how they are building a presence in Asia – from drug development to market. PharmAsia Summit will gather the industry’s most senior leaders to share best practice case studies, successful business models and strategic partnerships from discovery to clinical trials.

Join us for three days of interactive discussions, case studies and panels, and capitalize on Asia’s booming pharmaceutical market.

BEYOND THE BASICS! PharmAsia Summit is the only event featuring marquee level speakers and topics by the powerhouse editorial team from IN VIVO, START-UP, "THE PINK SHEET" and PHARMASIA NEWS. Discussions include:

* Heads of China R & D Roundtable: A Look at Different Models for Approaching Innovation in China * China’s Changing Regulatory Landscape: The future of Chinese Healthcare Reform and What it Means for both Multinational and Chinese Companies * Regulators Up Close: What can We Expect from Market Regulators in Asia? * Indian Perspective on Globalization * Partnering For Success In Emerging Markets: How Strategic Partnerships and M & A have Changed the Face of R & D in Asia * Investment Outlook For Asia: VC Perspectives on their Best Bets * Tips for Success: Working and Partnering with a CRO in Asia * Building a Sales and Commercial Presence in China: How Do You Maximize Market Opportunities? * Overcoming Intellectual Property Issues in Asia * How to Conduct U.S. FDA Inspections in China***********************************************************************************Bio2Device Group, Tuesday Morning, Oct. 27, 2009

Topic: “Effective Transfer of Complex Biological Methods in the GMP/GLP Environment “Speaker: Ana T. Menendez, Ph.D., Senior Director of Biotechnology, CatalentDate and Time: Tuesday, Oct. 27, 2009, 8:30 – 10:30 amLocation: Sunnyvale City Council Chambers, 456 W. Olive, Sunnyvale, CA (across the street from Sunnyvale Public Library)Cost: FreeParking on street and in NOVA and library parking lots across the street.Further details will be posted at www.bio2devicegroup in September.

Topic Description50% of the drugs presently in discovery are biopharmaceuticals - these numbers lead to an "outsource or perish" philosophy for GMP/GLP development, validation and sample analysis. Unlike synthetic drugs requiring only

8 5/6/2023

straightforward analytical testing biopharmaceuticals require more elaborate assays to attain regulatory compliance. The industry has a significant underestimation of the discipline, skills and planning required to successfully transfer these assays. Naiveté in this area causes loss of precious time and money during development. This seminar systematically outlines the steps needed to successfully transfer validated biological assays between GMP/GLP labs and also acquire non-validated assays for GMP/GLP development. Topics to be addressed are:- Setting a realistic timeline for your assay transfer- Issues that need to be addressed in preliminary discussions between the labs- Proper method writing- Parameters to be evaluated during the transfer protocolParticipants in this seminar will attain a valuable checklist of critical information that will reduce delay and confusion during method transfer. The hands-on, common sense approach will provide a chronological pathway that can easily be adapted for any complex assay.

Speaker BioAna T. Menendez, Ph.D., implemented GMP/GLP biotesting at Catalent with the following services: Cellular Technologies, Molecular Technologies and Virology. The expertise of the department ranges from recombinant proteins to therapeutic viruses, bacterial vaccines and aptamers. Dr. Menendez joined Catalent from Bristol-Myers Squibb (BMS) where she held a number of positions of increasing responsibility from 1995 to 2001. As the head of the Cancer Cell Biology department Dr. Menendez worked on several compounds currently in clinical trials, including second-generation taxanes and inhibitors of the ras and src oncogenes. While Associate Director of Regulatory Sciences she assisted the transition of Oncology and Infectious Diseases leads from the lab bench to the clinic. From 1982 to 1995, Dr. Menendez pioneered monoclonal antibody technology at American Cyanamid/Wyeth and was responsible for all the immunoassays and in vitro bioassays for Mylotarg, an anticancer monoclonal antibody – toxin conjugate that was approved in 2000.

Dr. Menendez obtained her Ph.D. in Microbiology/Immunology in 1995 from NY Medical College while simultaneously fulfilling her supervisory functions at Wyeth. She is an international instructor and consultant on Development and Validation of Bioassays.

***************************************************************************************

Bio2Device Group, Tuesday Morning, Nov. 3, 2009

Topic: "7 Steps to a Successful Life Science Startup"Speaker: Naeem Zafar, CEO of 3 Silicon Valley startups and Faculty Member at UC Berkeley Haas Business School,  business author-www.startup-advisor.com  and www.ConcordiaVentures.com Date and Time: Tuesday, Nov. 3, 2009, 8:30 – 10:30 amLocation: Sunnyvale City Council Chambers, 456 W. Olive, Sunnyvale, CA (across the street from Sunnyvale Public Library)Cost: FreeParking on street and in NOVA and library parking lots across the street.Topic Description  This talk will outline the steps needed for entrepreneurs to launch their startups.  Two questions that face any entrepreneur are: “when do I know that I am ready to quit my day-job” and “am I investor-ready”.  This talk will answer both of these questions.  An interactive and high energy talk will look at the overall process of starting up and what it takes to get attention from investors interested in life science companies.   

Speaker BioNaeem Zafar has extensive experience in advising entrepreneurs on starting new ventures. Naeem is a faculty member at the University of California, Berkeley, where he teaches entrepreneurship and innovation at the Haas School of Business.Naeem has worked in Silicon Valley for many startups, serving as the president and CEO of three of them. He served as a member of the Board of Directors or as a Board advisor for several startups and small companies.He has launched products in several countries. As a part of  his advisory positions, he has helped several companies in life sciences and medical device startups.

9 5/6/2023

Naeem has raised over $70 million from venture capitalists, angel investors public markets, and venture debt from banks.He led or played critical roles in over a dozen mergers and acquisitions. Naeem advises founders and CEOs in multiple countries, giving them information and feedback that helps them start and scale their businesses. Naeem advises governmental organizations regarding how to create an ecosystem of innovation.

***************************************************************************************

Licensing Executives Society, SF Chapter, Thursday Lunchtime, Nov. 5, 2009

Topic: University Technology Transfer - A Comparison of U.S. and European ApproachesPanel:Teri Willey, Chief Executive of Cambridge Enterprise LimitedThe commercialisation office of the University of CambridgeKatharine Ku, Director of the Office of Technology Licensing (OTL)Stanford UniversityDate and Time: Thursday, November 5, 11:30 AM – 2:00 PM11:30 AM - 12:30 PM: Lunch & Registration12:30 PM - 1:30 PM: Presentation1:30 PM - 2:00 PM: Q&A & NetworkingLocation:: Kirkland & Ellis LLP, 555 California Street, 27th Floor, San Francisco, CA 94104Click here for more information and online registration

Online RegistrationEarly, by October 30, 9 PMLES Members: $35Non-Members: $40After October 30LES Members: $40Non-Members: $45Online Registration Deadline:  Wednesday, November 4For questions about the event:Rob WarnerLES SF Chapter Marketing Chairrob.warner@fticonsulting.com

**************************************************************************************

Triple Ring Technologies, Thursday Evening, Nov. 5, 2009

Topic: The Early History of MRIDate and Time: Thursday, November 5, 2009, 6:00 – 9:00 pm, presentation begins at 6:45 pmLocation: Triple Ring Technologies, 39655 Eureka Drive, NewarkSpeaker: Waldo Hinshaw, Principal Scientist, Triple Ring TechnologiesCost: The seminar is free of charge, but registration is required for planning purposesTo Register, visit http://www.acteva.com/booking.cfm?bevaid=177803 by Wednesday, November 4 at noonOn-Site registration: A limited number of on-site registrations may be available

Topic DescriptionTelevision shows from House to General Hospital include scenes where magnetic resonance imaging (MRI) is used. Indeed, chances are that you or someone you know has undergone MRI testing. Despite the number of people exposed to this technology, very few would be comfortable explaining how it works. As with many such

10 5/6/2023

technologies, even fewer would be able to describe in any detail how it came about. In fact, most of those who design and build MRI machines know little about its history.

This presentation will briefly review the basic ideas underlying MRI and then walk through the fascinating story of how Paul Lauterbur came up with the initial idea. Some of the intrigue and controversy surrounding the early days will be discussed. The development history of MRI provides a compelling look at the past and perhaps a window into future advanced technology development efforts.

Speaker BioWaldo Hinshaw has been working in the field of medical imaging for many years. His PhD research in the University of North Carolina Physics Department involved NMR (nuclear magnetic resonance) relaxation time measurements of various materials. After hearing about the first MR images during a lecture in Bombay in 1974, he returned to his lab in Nottingham and modified an NMR system so that it produced the second set of MR images.

He accepted an appointment as Associate Professor at Harvard Medical School with the goal of developing a clinical imaging system. It soon became clear that an industrial environment is better for developing state-of-the-art technology. He assembled a group within the Cleveland company, Technicare, which was the first company to ship significant numbers of clinical systems. Currently, he is working for Triple Ring Technologies and involved with other nascent imaging technologies.

**********************************************************************

NCC, ACRP, Thursday Evening, Nov. 5, 2009

Event:   Northern California Chapter Holiday Event: Dinner, Networking, including NCC ACRP Board Elections, Bylaws Approval, & Year in Review AND“Careers in Life Sciences 2009” Speaker: Toby Freedman, Ph.D., Synapsis SearchDate and Time:: Thursday, Nov. 5, 6-9 pmAgenda:         6:00 – 7:00 PM Registration sign-in, Networking, & Dinner Buffet7.00 -8.00 PM: President's Welcome, Volunteer Certificates of Appreciation, Board elections, Bylaws revision, Raffles, Announcements                    8.00 - 8.50 PM: Presentation 8.50-9.00 PM: Continue Q&A, networking; complete & turn in board ballots and bylaws votes. Location:Menlo Park VA, Auditorium Room B-200; Building 334, 795 Willow Road, Menlo Park,  CA  94025 EVENT REGISTRATION through Monday, 02 November 2009   Register early to assure admission; at event IF space available REGISTER  NOW --CLICK ON REGISTER NOW! NCC ACRP Member  Free ACRP Member   $10 Non-ACRP Member $15 Non-ACRP Member Walk-in $20 Contact hours are not offered for this event Instructions for Event Attendees NCC ACRP registration / purchase refund policy: no refunds. No transfers. Membership not required for online registration. Questions? Renisa Satrijo at rsatrijo@gmail.comProgram Description 2009 has been a year of year of surprises and challenges for the life sciences industry. What will 2010 bring? Our presenter will summarize the current landscape including - current trends in biotech, the future remains promising, what are the hot jobs, and why we're motivated to work in this industry.  She'll also review career

11 5/6/2023

planning and development approaches - personality attributes for successful careers, job search strategies, how to identify your ideal job, and moving up the career ladder.

Speaker Bio Toby Freedman is an author and Founder/President of Synapsis Search.  A scientist by training, she transitioned into business as a recruiter, writer, and entrepreneur.  Her book Career Opportunities in Biotechnology and Drug Development provides a comprehensive overview of the many careers in the life sciences industry ranging from venture capital to marketing to discovery research. She recently started her own recruiting firm, Synapsis Search, which is focused on executive R&D and business placements in the life sciences industry. She previously worked at BioQuest, an executive search firm, and as Director of Business Development at SLIL Biomedical, a drug discovery company developing therapeutics for cancer and other diseases. She earned a Ph.D. in molecular biology from UNC Chapel Hill, a B.S. from the University of California, and as an NIH Fellow, conducted postdoctoral research at Harvard University and at the University of Texas-Austin. Toby is the Program Chair for the BioScience Forum, a leading non-profit educational forum serving the Bay Area biotechnology community and teaches career development for the life sciences at UC Berkeley Extension.

Target Audience:

Clinical Research Professionals Sponsor Organizations Study Site Investigators & Coordinators Independent Consultants Students of Clinical Research Academic Medical/Clinical Researchers Service Providers/Vendors Institutional Review Boards Quality Assurance

Directions to the Menlo Park VA Auditorium From 101, take the Willow Road exit going west Turn RIGHT at the second stoplight, entering the VA grounds Turn RIGHT at the stop sign onto Hospital Plaza Turn LEFT at the stop sign onto Redwood Ave Bldg 334 will be on your left; Park in Lots 334 or 323 Take the elevator or stairs to the 2nd floor of Bld 334 The speed limit is 15MPH!

*******************************************************************

Fountain Blue’s Funding Road Trip, Friday Morning, Nov. 6, 2009

FountainBlue's Funding Road Trip: “Perfecting Your Pitch to Investors”Date and Time:        Friday, November 6, 8:30 a.m. - 1:30 p.m.Agenda for the Pitch Workshop:8:30    Registration and Networking9:00    Bill Joos: Perfecting Your Pitch to Investors10:30  Morning Break 10:45  Pitch Practice Sessions - 6-10 teams, 15 mins a team, no official break for lunch1:00   Optional Pitch Debrief Meeting Facilitated by Bill Joos1:30   Adjourn. Please note that we have the room until 1:45 p.m. and we welcome you to stay to network fellow entrepreneurs.Location: Cooley Godward Kronish, LLP, 3175 Hanover Street in Palo AltoAudience:  Early-Stage, Funding-Bound Clean Energy, High Tech and Life Science No Service Providers, Please

12 5/6/2023

Cost for 2 Entrepreneurs: $80 for FountainBlue members, $85 for Partners, $90 General, $100 On-Site. An additional fee of $4-$5 will be added for processing.Registration: Please pre-register by noon on 11/4 using the PayPal link at http://www.fountainblue.biz/fundingroadtrip.html. Late and on-site registration is $100 if e-mail is time stamped after that, regardless of membership status.

 About the Funding Road Trip Series:

These events are for Silicon Valley-based high tech, life science and clean energy entrepreneurs from the FountainBlue community and beyond.

The interactive and collaborative nature of this initial workshop requires two representatives from each start-up company to attend.

Attendance at one of the first two workshops in the series is a pre-requisite for attending the final workshop, which features a presentation to active investors.

Additional representatives from the same company may attend for a nominal additional fee. Each session will start at 8:30 a.m. and end between noon and 1 p.m. Space is limited so we strongly suggest early pre-registration.  No service providers are allowed, unless they are invited speakers or current sponsors.

For more information about FountainBlue's Funding Road Trip Series including testimonials and speaker bios, please visit http://www.fountainblue.biz/fundingroadtrip.html.

Topic DescriptionFountainBlue cordially invites high tech, life science and clean energy entrepreneurs to the second funding preparation workshop entitled Perfecting Your Pitch to Investors. This hands-on workshop, the second in the FountainBlue Funding Road Trip series, will take entrepreneurs through the process of creating and delivering a compelling elevator pitch, a one-page executive summary and a 13-15 slide company overview presentation. Working in partnership with fellow entrepreneurs in similar, non-competing spaces, participating entrepreneurs will have the opportunity to learn best practices and immediately apply these learnings to their own companies. Whether you are a serial entrepreneur, or someone who may be considering a future opportunity, you are sure to benefit from the information presented, the connections made and the peer-to-peer knowledge shared.

Speaker BioBill Joos is the principal of "Go To Market Consulting", based in Palo Alto, CA. He works with early stage startups, venture capital firms and their portfolio clients. Most recently he spent 6 years as the VP of Entrepreneur Development at Garage Technology Ventures, an early stage venture capital firm that he co-founded along with Guy Kawasaki. His reputation at Garage was that he provided their clients with effective, hands-on, action-oriented strategic and tactical mentoring and coaching. Bill has worked with literally hundreds of early-to-mid stage startups and helped them polish and clarify their messages and refine their fund-raising and customer presentations; but his contributions to them extended well beyond being a "Pitch Doctor". He has mentored and coached them in go to market strategies, revenue and pricing optimization, business alliances, business development, partnerships, and marketing. Over 15,000 entrepreneurs worldwide have attended conferences where Bill has been a featured keynote speaker on various entrepreneurial topics. He has held sales and marketing positions with a variety of companies, including IBM and as a VP of the software division of Apple Computer.

*************************************************************************************

UC Berkeley Extension Career Course, Saturday Afternoon, Nov. 7, 14 & 21, 2009

Event: Career Opportunities in Biotechnology and Drug DiscoveryInstructor: Toby Beth Freedman, Ph.D, Principal, Synapsis Search and Author, Career Opportunities in Biotechnology and Drug DevelopmentDates and Time: 3 meetings, Nov. 7–Nov. 21: Sat., 1–6 pm

13 5/6/2023

Location: Redwood City: Peninsula Center,1991 Broadway St.

Enroll Nowwww.unex.berkeley.edu(510) 642-4111Cost: $750 (EDP 401729)

Course DescriptionIdentify a biotechnology career path that best suits your interests, skill sets, and career goalsin this one- or three-day course (depending on location). Develop an understanding of avariety of career paths in biotech including venture capital, sales and marketing, businessdevelopment, clinical and regulatory affairs, and project management. You also get practicaljob search advice on topics such as informational interviews, résumé writing, networking, andinterviewing strategies.

Speaker BioToby Beth Freedman, Ph.D., is the author of Career Opportunities in Biotechnologyand Drug Development and owner of Synapsis Search, a life sciences recruiting company.She has a Ph.D. in molecular biology from UNC Chapel Hill.*******************************************************************************Bio2Device Group, Tuesday Morning, Nov. 10, 2009

Topic : “Acquire and Fire! Utilizing robotics and image guidance to annihilate cancer”Speaker: Michael Saracen, Director of Product Development for IGRT & Robotics at Civco Medical SolutionsDate and Time: Tuesday, Nov. 10, 2009, 6:00 – 9:00 pmLocation: Location: TIPS Group Law Offices , 1000 Elwell Court, Palo Alto, CA 94303Advanced registration is required: See www.bio2devicegroup.org website a week prior to event for preregistration detailsCost: Fee for light dinner with range depending on timing of registration:

Topic DescriptionRobots are commonplace in many industries today demonstrating the benefits reliability, precision and accuracy have to offer. Medicine is starting to embrace technology, realizing some tasks are performed better and in some cases better performed by a machine. One area which has greatly benefited from this marriage of technology and medicine is Radiation Oncology. Targeting tumors inside the body with high precision and accuracy throughout a treatment is challenging, often requiring immobilization devices to prevent the patient from moving. The problem becomes significantly more difficult when treating tumors that move with respiration like those found in the lung, liver or pancreas. One system, the CyberKnife, has successfully integrated robotics into patient setup and delivery of radiation, making treatments safer and more precise. Leveraging fully integrated image guidance capabilities, the system automatically adapts to movements and changes in the patient’s breathing patterns without user input. Robotics has a place in medicine, the question is, to what extent does it improve patient care and can reduce costs in the long run.

Speaker BioMichael Saracen is the Director of Product Development for IGRT & Robotics at Civco Medical Solutions. He has over 15 years experience creating, patenting, developing and launching new products and services into the medical device industry. Prior to Civco Michael worked at Accuray Inc. as director of product management and product marketing departments overseeing all aspects of the product lifecycle. Before Accuray, Michael worked in three different medical device companies overseeing their Image Guided Surgery product lines. He has extensive experience in robotics, biomaterials, radiation delivery and medical software systems. Michael received his Masters from Brown University in Biomaterials and Artificial Organs. Prior to getting his masters he worked in protein biochemistry research in the Orthopedic Department at Rhode Island Hospital.

While at Accuray Michael was a lead inventor on the RoboCouch, a fully robotic patient positioner, and took

14 5/6/2023

the product from concept to prototype in 6 months and received FDA clearance within 9 months. Michael has 9 issued and 10 pending patents covering robotics, quality assurance, tracking & vision systems and treatment planning software.

***************************************************************************************

Golden Gate Polymer Forum, Thursday Evening, Nov. 12, 2009

Topic: "Polymer and Pharmaceutical Materials Characterization Under Dynamic Humidity Atmospheres" Speaker: Steven R. Aubuchon, TA Instruments, Newcastle, Delaware

               Discounted Early Registration Ends 5pm Wed. Nov. 4

Date and Time: November 12,

Timing:       6:00 PM  social hour                  7:00 PM  dinner                  8:00 PM  presentation

Location: Michael's at 2960 N Shoreline Blvd. , Shoreline Park, Mountain View   http://www.michaelsatshoreline.com/location.html

Dinner Selections:        Salmon         Chicken portobello         Grilled vegetable brochette

Cost:   Employed/postdocs:  $30 with advance registration, $35 normal registration          Unemployed/retired/students:  $15 with advance registration, $20 normal registration            After deadline:  registration not guaranteed, so contact us                     late fee applies -- $40 regular/employed, $25 unemployed/student/retired           Free if you attend just the lectures at 8:00 PM (but please let us know for headcount)

Deadline for registration:    5 pm Nov. 11 (but please try to do so earlier if you can; it helps) Early Registration Ends 5pm Wed. Nov. 4.Because we must pay the restaurant for the ordered meal, we must ask no-shows to pay for their reservation.  

PLEASE NOTE:  we accept cash or checks, but are unable to accept payment by credit card at this time.   You may pay at the door.

Please register on the web page              www.GGPF.org

Or, if necessary, contact:        Len Radzilowski         lradzilo@tycoelectronics.com         650-361-3264

You should receive confirmation of your registration; if not, please contact us again.                        

15 5/6/2023

Topic DescriptionTraditional thermal analysis experiments were typically performed under inert atmospheres, with limited consideration of the effects of reactive or humid atmospheres.  However, in practice it is virtually impossible to eliminate water from processing, storage or end-use of most materials.  As such it is important to create and control dynamic atmospheres, and to measure thermal and mechanical properties taking into account the effects of water.  Modern instrumentation now provides for the simultaneous direct control of both temperature and relative humidity, applied to both gravimetric and dynamic mechanical analyses.  In this seminar, moisture sorption analysis will be introduced and discussed, as it relates to a wide range of organic and polymeric materials whose applications include pharmaceuticals, electronics, fuel cells, and packaging.  Detailed examples from both gravimetric and dynamic mechanical analysis applications will be presented and discussed.

Speaker BioSteve Aubuchon is Product Manager for TA Instruments-Waters, LLC.  He has been with TA Instruments since 1994, holding positions in applications, product development, technical support and sales.  Steve earned a Ph.D. in inorganic physical chemistry from Duke University and a B.S. in chemistry from St. Louis University.  He has authored over 30 literature publications and has presented invited lectures, seminars and training courses in the field of thermal and mechanical of materials in over 20 countries worldwide.  

In addition to his work at TA Instruments, Steve holds an appointment as Adjunct Professor of Chemical and Life Sciences Engineering at Virginia Commonwealth University in Richmond, Virginia (USA).

********************************************************************

CBA, Saturday Afternoon, Nov. 14, 2009Topic: “Annual Conference: Emerging Trends in Biotechnology Industry” Date and Time: Sat, Nov 14, 2009, 1:00- 5:30 PMLocation: Double Tree Hotel San Jose 2050 Gateway Place, San Jose, California 95110

Online registration: Oct 3 - Nov 12, 11:30 PM Please check our website for details and register now at www.cbasf.orgOn site registration: Starts at noon, Nov 14. Seatings will be very limited for on site registration.

Conference: Dinner with seminar: Starts at 6:30 PM at the same location

For CBA Members:     Conference Only          Free   Conference and Dinner    $50For Non CBA Members and Students/Postdocs:   Conference Only          $10   Conference and Dinner    $60For Other Non CBA Members:   Conference Only          $20   Conference and Dinner    $70   CBA will pay for the parking at Double Tree Hotel.

Program Description

The theme of the conference is “Emerging Trends in Bioscience Industry”, with an array of scientific experts and business development leaders presenting the latest information on emerging biotechnological development and business opportunities around the world. .  Annual conference program

16 5/6/2023

12:00 – 1:00  Registration 1:00 – 1:15     Welcome & Opening Remarks                        Ms. Stella Chang, CBA President

Dr. Sydney Chen, Program Chairperson                      1:15 – 2:00     Bioscience: New Technology and Industry Outlook

Mr. Matthew GardnerPresident  & CEO, BayBioModerator:  Dr. Katy Korsmeyer

2:00 – 2:45     Stem Cell Application in Regenerative Medicine Dr. Jane LebkowskiSenior Vice President & CSO, Geron Corp    

                        Moderator: Dr. Shian-Jiun Shih2:45 – 3:00     Bio Fuel: Bioprocessing

Ms. Wei HuangVice President, LS9 Inc

                        Moderator: Cesar Ho3:00 – 3:20     Coffee Break3:20 – 5:20     Panel Discussion

Bridging US-Asia Biopharmaceutical Industry: Overview, Opportunities and Challenges

                        Chairperson: Dr. Jing-Shan HuDirector Licensing and External Research, Merck & CoDr. Larry Hsu, President, CEO & Director, Impax Laboratories

                        Dr. Jo Shen, President & CEO, ScinoPharm                        Dr. Marietta Wu, General Manager Greater China, Burrill & Company5:20 – 5:30     Closing Remarks                        Dr. Sydney Chen, Program Chairperson          5:30 – 6:00     Networking 6:00 – 9:30     Dinner

Keynote : Prof. Ginger Cheng-Chi Hsü 徐澄琪教授Department of the History of Art, UC-Riverside

 

******************************************************************************************

Bio2Device Group, Tuesday Morning, November 17, 2009

Topic: “Puzzles, Mysteries, and Complexities: Problem Solving in Life Science Organizations"Speaker: Jerry L. Talley, JLTalley and Associates and Deborah Lynne Lombardo, Executive Associate with Barnes & Conti AssociatesDate and Time: Tuesday, November 17, 2009, 8:30 – 10:30 amLocation: Sunnyvale City Council Chambers, 456 W. Olive, Sunnyvale, CA (across the street from Sunnyvale Public Library)Cost: FreeParking: On street and in NOVA and library parking lots across the street.

Topic DescriptionOn the door of every manager, project managers, or team leader an invisible sign that says "Bring your problems to me", or at least that's how people behave. –And in an industry characterized by innovation and research, you can be guaranteed a high volume of problems to solve. If you're lucky you have your team members to deal with their own problems.

Whether you work on your own or through a team,, your fluency in problem solving is a key component of your success. Dr. Jerry Talley (Professor of Sociology at Stanford University-retired) and Lynne Lombardo of

17 5/6/2023

Barnes & Conti Associates will share some new thinking in the art and science of problem solving that can give you a faster, more powerful way to think through the inevitable problems in any endeavor. Dr. Talley’s research over 10 years of examining business problems and how people solve them revealed that there are really only 6 types of problems and each problem has a best strategy for finding a solution. By accurately identifying the fundamental type of a problem rather than treating every problem with the same approach, you and your team members will save time, resources and increase good will -- not to mention fewer sleepless nights. Please join us to learn about the 6 problem types, the components of an ideal problem-solving group, and key skills you’ll need in your role as leader or facilitator.

Speaker BiosJerry L. Talley is a veteran of multiple careers. He started with 18 years on the Stanford University faculty in the department of Sociology. While there he also had a private practice as a Marriage Family Therapist for 10 years. And almost 30 years ago he moved into organizational development consulting. He has worked with over 300 clients in the Bay area, nationally, and some international. He has consulted to companies in high tech, pharmaceuticals, hospitals and health care, banking and finance, consulting houses, the military, manufacturing, public utilities, public sector, not-for-profits, publishing, hospitality, entertainment, and one organic grocery store. He specializes in strategic planning, non-profit governance, and advanced problem solving and decision-making. His practice is summarized on www.JLTalley.com.

Deborah Lynne Lombardo has more than 25 years’ experience in providing creative and practical approaches to developing high performance in organizations. At UCLA’s Anderson School of Management, she became convinced that the true challenge of any endeavor is to mobilize human talent, energy, and brilliance to achieve extraordinary results. This has been her focus ever since.

Lynne’s career has built a broad base of management, sales, and consulting experience that have benefited organizations on every continent except Antarctica. Her clients have come from nearly every sector of the economy: financial, manufacturing, high tech, communications, insurance, biotech/pharmaceutical, education, transportation, energy, health-care and not-for-profit theaters such as The Marsh and ACT in San Francisco. Her interest these days is on building high performance through better problem solving approaches; and helping companies to grow through innovative sales approaches.

Among other affiliations, Deborah Lynne is an Executive Associate with Barnes & Conti Associates who has partnered with Jerry to bring his problem solving methodology to a wider audience. Learn more at www.barnesconti.com

*************************************************************************************

Palo Alto AWIS, Wednesday Evening, November 18, 2009

Topic: “10 Top Tips for Using Linked In Effectively”Speaker: Patrice Reid, Career Management Consultant,Right Management http://www.right.comDate and Time: Wednesday, Nov. 18 2009, 7:00 pm - 9:00 pm Schedule7:00-7:30 pm Networking and light supper7:30-7:45 pm Announcements7:45-8:45 pm Program8:45-9:00 pm Discussion

Location: Palo Alto Research Center (PARC), 3333 Coyote Hill Road, Palo Alto Directions to PARC.

For details and to register, http://www.acteva.com/go/pa-awis

Welcome!!  You don’t need to be a member to attend.All scientists, students, and their friends are welcome.  Men too!

18 5/6/2023

Members pay $5 and non-members pay $10 to offset the cost of food.

 

Topic DescriptionLinkedIn is the tool that people and organizations are using to connect and build relationships. For scientists, it provides a rich source of information on "who", "what" and "where" that can lead to new sources of collaboration, funding and career opportunity.How can LinkedIn and other social media tools like Twitter and Facebook advance your career? Among the topics we'll be covering are: profile completeness, expanding your connections, handling recommendations, joining groups, and posting status messages. This presentation will be particularly helpful if you are using LinkedIn but not really optimizing it.

Speaker Bio

Our speaker, Patrice Reid, is a Career Management Consultant with Right Management in San Francisco. Patrice specializes in providing career transition, workshop facilitation and career consulting services for both companies and individuals. Her specialties include startup/entrepreneurship coaching and the use of social media tools in career management.

Directions from 280:

Take Hwy 280 and exit at Page Mill Rd and go East towards Palo Alto (if coming from the South, turn right, if coming from the north, turn left onto Page Mill. Turn RIGHT onto Coyote Hill Rd. Turn LEFT into PARC (formerly Xerox PARC).  Follow signs to the Auditorium on your left at end of parking area, down flight of outdoor stairs.

Directions from Stanford: Take Foothill SOUTH towards Los Altos. Turn RIGHT on Hill view and PARC is 2nd driveway on the right. Park and follow signs to the Auditorium (walk uphill through parking lot then down a flight of outdoor stairs).

See also http://www.tinyurl.com/PARC-Auditorium/   for map.For more info: www.pa-awis.org, or email awis.pa@gmail.com

**************************************************************************************

Bioscience Business Development: Building Value, Thursday and Friday, Dec. 3-4, 2009

Intensive Course: Bioscience Business Development: Building Value, Thursday and Friday, Dec. 3-4, 2009 ((2 days of classroom and 2 months to complete project guided by instructor)with 2 months to complete project Instructors: Audrey S. Erbes, Ph.D., Principal, Erbes & Associates and www.audreysnetwork.comand and Gilbert R. Mintz, Ph.D., President of GRM AssociatesExpert Guest Speakers: Ginger Dreger, J.D., M.S., Goodwin Procter Harold (Hal) Etterman, MBA, Business Strategist Carolyn Feamster, MBA, VP, Business Strategy & Analysis Tom Gutshall, Chairman & Co-Founder of Cepheid Michael G. McCully, M.S., Director, Recombinant Capital Please see www.ucsc-extension.edu/biobizdev for complete biographies Date & Time: Oct. 8-9, 2009, Thursday and Friday, 8:30am-5pmLocation: UCSC Extension in Silicon Valley, 2505 Augustine Drive, Santa Clara, CA 95053

19 5/6/2023

Fee: $770; $693 through Nov. 19 Please inquire about additional discounts for more than 5 attendees from the same company.

Topic DescriptionUCSC Extension in Silicon Valley presents a two-day intensive course that brings the breadth of the Bay Area’s biobusiness development expertise to our Cupertino classroom. Whether financing start-up activities, trying to keep pace with the current burn rate, or moving a product into the marketplace, bioscience companies, both large and small, have a critical need for business development at every stage of their evolution. Learn the key roles that business development and licensing play in the commercialization of a new product and the development of a successful bioscience company. Santa Clara, CA. For more information, see www.ucsc-extension.edu/biobizdev

Instructor BiosAudrey Erbes, Ph.D., Principal, Erbes & Associates and www.audreysnetwork.com has more than 35 years of marketing experience in the biotech and pharmaceutical industries, of which 25 years was in corporate management at Kowa Research Institute and Syntex Corporation.Gilbert R. Mintz, Ph.D., President of GRM Associates, a biotechnology consulting firm with expertise in business development, licensing and strategic planning.

**************************************************************************

San Jose Biocenter, Thursday Late Afternoon, Dec. 3rd, 2009

Topic: Trends in Financing Investor Panel & Holiday Celebration Invited speakers include:• Mike Powell, General Partner, Sofinnova Ventures• Sigrid Van Bladel, PhD, Partner, New Enterprise Associates• Casper de Clercq, Venture Partner, U.S. Venture Partners• Jennifer Fonstad, Managing Director, Draper Fisher Jurvetson• Doug Fisher, Principal, InterWest Partners LLC• Janis Naeve, PhD, Director, Amgen Ventures• Don Santel, Chief Executive Officer, Hyperion Therapeutics Date and Time: Thursday December 3, 2009 | 3pm-6:30pm Location: Orrick, Herrington & Sutcliffe LLP, 1000 Marsh Road, Building 1100, Menlo Park, CA 94025-1015Click here for Venue Directions»

This event is typically sold out, so pre-registration is recommended to avoid disappointment on the day!• Regular Price: $60• Partners' Network: $50• BioCenter Members: Free (please RSVP to Aurélie)• On-site Registration: add $10 to the above

Topic DescriptionSteady capital is a must for all companies.  The first step in funding is knowing where to look.  Join experts from the investment world to understand the types of financing that are occurring in your industry today, and what can be expected for 2010. Our Panel discussions are candid, interactive and informal. We want you to walk away with the real story behind how things work so you can make it happen yourself. This Panel will be followed by a Holiday Celebration Networking Reception.

******************************************************************************************Bio2Device Group, Tuesday Evening, Dec. 8, 2009

20 5/6/2023

Topic: “Science + Commercialization = Valuation. Building a Commercial Story that Resonates with Prospective Partners.”Speaker: Harris Kaplan, President and Chief Executive Officer, HealogixDate and Time: Tuesday, Dec.. 8, 2009, 6:00 – 9:00 pmLocation: Location: TIPS Group Law Offices , 1000 Elwell Court, Palo Alto, CA 94303Advanced registration is required see bio2devicegroup.org website for details a week prior to event.Cost: Fee for light dinner with range depending on timing of registration:

Topic Description

The biotech IPO window has been closed for some time now and is unlikely to reopen anytime soon. As a result, biotech executives are increasingly reliant on a big pharma or big biotech to provide the capital needed to continue to develop promising new compounds and the competition for pharma or biotech dollars is intense. The larger companies differ significantly from financial investors. They are at least as concerned about how the product will perform in the market post launch as they are about the science. Thus, it is as important for a biotech executive understand the commercialization opportunity and to make that story come to life for an executive. Think venture capital but without a requirement that “monies have to be put to work.”  A biotech executive has to make one of these larger companies want to do a deal with your company.

This talk will focus on how biotech executives go about building a robust commercial story – what elements need to be included in that story and how to position compounds so they are very attractive to pharma and big biotech scientists and business development executives. Most biotech deals get one opportunity to present their technology and/or product. This talk will help company executives make that one time count.

Speaker BioHarris Kaplan is currently President and Chief Executive Officer of Healogix, a consultancy formed in late 2005 that advises companies on how to create and maximize the value of new products in development.Harris has extensive experience in the pharmaceutical industry both on the client and consulting side of the business and has worked on the introduction of more than 75 new products including Lipitor, Crestor, Nexium, Rituxan, and Herceptin.

Harris co-founded Migliara-Kaplan Associates which became the world’s largest custom marketing research company serving 19 of the top 20 pharmaceutical companies. Migliara-Kaplan Associates specialized in helping companies identify new product opportunities and then maximizing the commercial potential of new products in development. Migliara-Kaplan was acquired by NFO in 1996 and is now part of TNS Healthcare. Harris was also cofounder of Cozint Interactive which was acquired by GFK, the German based research company. Harris serves as an advisor to several venture capital funds and is on the Board of Directors of Informedix and the Kernan Orthopedic Hospital.

21 5/6/2023